Analysts raised the price target to $111 from $99, citing the company's low-risk global gold portfolio. The stock has risen 26% in three months, supported by record high gold prices and strong free cash flow, which more than doubled to $1.6B in Q3. A planned 2025 capital expenditure cut is expected to further support cash flow. The average brokerage recommendation is a Buy, though some caution exists regarding the stock's recent rally and falling production levels.